The Brain Map Shouldn’t Get $100M a Year. It Should Get Much More

4/8/13Follow @xconomy

The human brain, as Francis Collins recently said, “is the most complicated organ in the universe.” We only have vague ideas today of how it works at the level of genes, and neural circuits. Deeper understanding could help us unravel some of today’s great mysteries, from autism to Alzheimer’s to epilepsy.

The sequencing of the human genome was controversial for a long time, but it’s starting to pay off with a new wave of genomic-based diagnostics and treatments. Venturing next into the unknown frontiers of the brain is an opportunity so big, so important, so darn interesting, it should be something our society eagerly supports and expects to pay dividends far in the future.

Yet the inspired idea known as the “Brain Activity Map” runs the risk of becoming a casualty of small-bore thinking in science, politics, and business. In a world where “sequester” has entered everyday spoken language, many politicians and scientists are tiptoeing around, afraid of vocally supporting something perceived as too risky, too ambitious, too unrealistic. But the truth is we can afford it, we can actually afford to spend a lot more on it, and it would be a wise investment of tax dollars.

Many readers have surely seen the headlines from last Tuesday, but for those who haven’t, here’s a recap. President Obama, after alluding to a brain project in his State of the Union address in February, formally proposed a $100 million first-year budget in 2014 for the Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) initiative. The goal of this project isn’t clearly defined yet, but loosely speaking, it’s about inventing new technologies to help scientists explore the complex circuitry of the human brain in action. We’re talking about our first serious glimpse into how those 1,000 trillion connections in the human brain work.

Obama, ever the gifted communicator, saw the poetry in this adventure.

“As humans we can identify galaxies light years away, we can study particles smaller than an atom, but we still haven’t unlocked the mystery of the three pounds of matter sitting between our ears,” Obama said on Tuesday.

Immediately, critics spoke up, mostly from some quite nervous camps within science. The goals weren’t clear from the outset, so it’s not really like the Human Genome Project, they said. The funding is small potatoes, not enough to make an impact. The tools don’t yet exist to gather data we need to even ask some of the important questions. There aren’t enough theoreticians in the NIH working group to crystallize the right questions to ask. There aren’t enough nanotechnologists in the group to invent the tools. Why not leave this kind of work to industry, some rich foundations, and billionaire philanthropist Paul Allen? The NIH budget is getting whacked across the board by sequestration, so why start something new? Aren’t we, as a nation, supposed to be broke?

All of those criticisms had made their way to George Church, the prominent genomics innovator at Harvard Medical School, by the time I stopped by his office in Boston about 48 hours after the White House press conference. Church, a veteran of the original Human Genome Project political debates of 30 years ago, has been part of a small group of scientists pushing this brain initiative for the past year through a series of articles in Science, Neuron, and ACSNano.

Genomics innovator George Church, pictured in his office at Harvard Medical School

Church, no surprise, sounded upbeat about what BRAIN can accomplish, starting with the early meetings that have helped define its objectives. “We called it a ‘Brain Activity Map’ to distinguish it from anatomical maps,” Church says. “The new acronym, which has a capital ‘N’ in it, stands for neurotechnologies, as in plural. I like that because the emphasis is not on a map, which sounds kind of static, even if you put the word ‘activity’ in front of it. It sounds a little monolithic, and we were a little OCD [obsessive compulsive] to get that last synaptic link.”

You can almost hear Church, in comments like this, doing his best to disarm the scientific critics that he remembers from the genome project days. Back then, people worried that a “big science” project would siphon money away from other worthy science projects—namely their own. People wondered what the heck we’d learn anyway, since most of the genome was thought to be meaningless “junk.” At the beginning, the sequencing technologies didn’t really exist to give us a full genome map in a reasonably cost-effective way. Besides, who wanted to work on the mere engineering task of automated sequencing, when graduate students were plentiful and worked on manual sequencing for dirt-cheap wages?

Building on the lessons of the genome project, Church is determined to deliver this time on a project that … Next Page »

Single Page Currently on Page: 1 2

By posting a comment, you agree to our terms and conditions.

  • Phdnofuddy

    I am a scientist and I certainly agree with the value of supporting basic research to some level. However, to claim that patient treatments will emerge with any level of cost-effectiveness from this approach is the traditional definition of insanity – repeatedly doing the same thing and expecting a different result. Where do treatments emerge and from what intellectual property – not from government or academia. If the govt wants to invest $100M, it should increase the knowledge base of the grants management infrastructure and align its tech transfer processes to the realities of today’s and future economics. I have never seen a system put up more barriers to true cost effective product translation than the structure we the taxpayers have funded over the years.

  • Roger Ramjet

    “…it would be a wise investment of tax dollars.” Let’s be clear, all of the money to be spent on this is borrowed.

  • http://www.facebook.com/john.lamuth John LaMuth

    A brain mapping solution is already in place with respect to the introduction of first “Periodic Table for the Human Forebrain,” which enjoys similar advantages to the dramatic influence that the Periodic Table of the Elements has enjoyed with respect to Chemistry and Physics.
    This respective neural counterpart imparts a crucial sense of systematic order and purpose to the fragmented state of affairs currently prevailing within the neurosciences.
    The cerebral cortex represents the most logical initiation point for such an innovation, celebrated as the crowning culmination of human forebrain evolution. This radical expansion of the neocortex is observed to occur in a discrete pattern suggestively termed cortical growth rings. The general pattern of neural evolution specifies that older structures are periodically modified to create newer functional areas, with the precursor circuitry also preserved, all persisting side by side. The stepwise repetition of these processes over the course of mammalian evolution ultimately accounts for the six sequential age levels of cortical evolution, the entire surface of the cortex folded flat so that the medial and sub-temporal surfaces are fully exposed.
    Returning to the dual parameter grid, the two fundamental variables defining forebrain evolution are the parameters of phylogenetic age and input specificity. The precise number of elementary levels has accurately been determined for both basic forebrain parameters. Sanides (1972) proposed that the human cortex evolved as a sequence of five concentric growth rings comprising a medio-lateral hemisphere gradient. Furthermore, the interoceptive, exteroceptive and proprioceptive input categories each project to their own four-part complex of cortical bands that (when taken collectively) define an antero-posterior hemisphere gradient.
    The evolutionary gradient extending from the archaecortex via the cingulate gyrus is essentially the top half of the dual parameter grid. Here, when the para-coronal variable of phylogenetic age is plotted as the ordinate and the para-sagittal parameter of input specificity charted as the abscissa in a Cartesian coordinate system, the resulting dual parameter grid depicted is spatially oriented in a pattern analogous to the standard cortical representation.
    The evolutionary gradient extending from the paleocortex via the insular lobe is the bottom half of the dual parameter grid. This version similarly shows that the human cortical parcellation schemes of Brodmann (1909) and von Economo (1929) correlate topographically on essentially a one-to-one basis with the dual parameter grid.
    Each cortical area described by Brodmann and von Economo corresponds to schematically unique age/input parameter coordinates. Furthermore, each affiliated thalamic nucleus of specific age and input coordinates projects principally to that cortical area comprising identical pair-coordinate values, implying that the evolution of both the dorsal thalamus and the cortex are similarly defined in terms of the specifics for the dual parameter grid. More details posted at http://www.forebrain.org
    5 min video at
    http://www.youtube.com/watch?v=p8kL3v539D4&list=UUpu6qc2aGZNdzHCSvBdMi-A&index=1&feature=plcp
    Sincerely
    John E. LaMuth MSc
    http://www.world-peace.org

  • http://www.socialbakers.com/events/engage Anne Goulding

    “The Brain Map Shouldn’t Get $100M a Year. It Should Get Much More”. Well, this will always be a really disputable question – how much should each company (or better to say idea) invested in. Who’s to say, how much it should be and who’s to say why the money shouldn’t be invested elsewhere? However, the Brain Map is a really great concept and I’d like to see much from it in the future.